Wahren B - Search Results

1

Specific properties of shRNA-mediated CCR5 downregulation that enhance the inhibition of HIV-1 infection in combination with shRNA targeting HIV-1 rev.

Cardona ME, Hinkula J, Gustafsson K, Christensson B, Wahren B, Mohamed AJ, Smith CIE, Arteaga HJ. Cardona ME, et al. Among authors: wahren b. Mol Biol Rep. 2022 Nov;49(11):11187-11192. doi: 10.1007/s11033-022-07899-9. Epub 2022 Sep 12. Mol Biol Rep. 2022. PMID: 36098885 Free PMC article.

2

Primary murine cells as a model for HIV-1 infection.

Lund LH, Ljungberg K, Wahren B, Hinkula J. Lund LH, et al. Among authors: wahren b. AIDS. 2004 Apr 30;18(7):1067-9. doi: 10.1097/00002030-200404300-00016. AIDS. 2004. PMID: 15096811

3

Elimination of HIV-1 infection by treatment with a doxorubicin-conjugated anti-envelope antibody.

Johansson S, Goldenberg DM, Griffiths GL, Wahren B, Hinkula J. Johansson S, et al. Among authors: wahren b. AIDS. 2006 Oct 3;20(15):1911-5. doi: 10.1097/01.aids.0000247111.58961.60. AIDS. 2006. PMID: 16988511

4

Accumulation and activation of natural killer cells in local intraperitoneal HIV-1/MuLV infection results in early control of virus infected cells.

Johansson SE, Brauner H, Hinkula J, Wahren B, Berg L, Johansson MH. Johansson SE, et al. Among authors: wahren b. Cell Immunol. 2011;272(1):71-8. doi: 10.1016/j.cellimm.2011.09.005. Epub 2011 Sep 22. Cell Immunol. 2011. PMID: 22019129

5

Induction of HIV-1-specific immunity after vaccination with apoptotic HIV-1/murine leukemia virus-infected cells.

Spetz AL, Sörensen AS, Walther-Jallow L, Wahren B, Andersson J, Holmgren L, Hinkula J. Spetz AL, et al. Among authors: wahren b. J Immunol. 2002 Nov 15;169(10):5771-9. doi: 10.4049/jimmunol.169.10.5771. J Immunol. 2002. PMID: 12421957

6

Genetic immunization with multiple HIV-1 genes provides protection against HIV-1/MuLV pseudovirus challenge in vivo.

Hinkula J, Rollman E, Lundholm P, Benthin R, Okuda K, Wahren B. Hinkula J, et al. Among authors: wahren b. Cells Tissues Organs. 2004;177(3):169-84. doi: 10.1159/000079991. Cells Tissues Organs. 2004. PMID: 15388991

7

NK cell function and antibodies mediating ADCC in HIV-1-infected viremic and controller patients.

Johansson SE, Rollman E, Chung AW, Center RJ, Hejdeman B, Stratov I, Hinkula J, Wahren B, Kärre K, Kent SJ, Berg L. Johansson SE, et al. Among authors: wahren b. Viral Immunol. 2011 Oct;24(5):359-68. doi: 10.1089/vim.2011.0025. Epub 2011 Sep 29. Viral Immunol. 2011. PMID: 21958370

8

Receptor Binding by Cholera Toxin B-Subunit and Amino Acid Modification Improves Minimal Peptide Immunogenicity.

Boberg A, Stålnacke A, Bråve A, Hinkula J, Wahren B, Carlin N. Boberg A, et al. Among authors: wahren b. ISRN Mol Biol. 2012 Jul 15;2012:170676. doi: 10.5402/2012/170676. eCollection 2012. ISRN Mol Biol. 2012. PMID: 27335661 Free PMC article.

9

Choosing CCR5 or Rev siRNA in HIV-1.

Arteaga HJ, Hinkula J, van Dijk-Härd I, Dilber MS, Wahren B, Christensson B, Mohamed AJ, Smith CI. Arteaga HJ, et al. Among authors: wahren b. Nat Biotechnol. 2003 Mar;21(3):230-1. doi: 10.1038/nbt0303-230. Nat Biotechnol. 2003. PMID: 12610564 No abstract available.

10

Nucleic acid vaccination with HIV regulatory genes: a combination of HIV-1 genes in separate plasmids induces strong immune responses.

Hinkula J, Lundholm P, Wahren B. Hinkula J, et al. Among authors: wahren b. Vaccine. 1997 Jun;15(8):874-8. doi: 10.1016/s0264-410x(96)00257-5. Vaccine. 1997. PMID: 9234537

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

546 results

Search Page